Mesangial C1q Deposition in IgA Nephropathy: Does the Classical Complement Pathway Play an Independent Role?
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr A, Renfrow M
. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011; 22(10):1795-803.
PMC: 3892742.
DOI: 10.1681/ASN.2011050464.
View
2.
Tian S, Yang X, Luo J, Guo H
. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. Int Immunopharmacol. 2020; 88:106896.
DOI: 10.1016/j.intimp.2020.106896.
View
3.
Berthoux F, Mohey H, Afiani A
. Natural history of primary IgA nephropathy. Semin Nephrol. 2008; 28(1):4-9.
DOI: 10.1016/j.semnephrol.2007.10.001.
View
4.
Hayashi A, Kawabe M, Yamamoto I, Ohki Y, Kobayashi A, Ueda H
. Clinical and Pathological Significance of Mesangial C1q Deposition in Kidney Transplant Recipients with Recurrent IgA Nephropathy and Patients with Native IgA Nephropathy. Nephron. 2023; 147 Suppl 1:80-88.
DOI: 10.1159/000530916.
View
5.
Roberts L, Williams C, Oni L, Barratt J, Selvaskandan H
. IgA Nephropathy: Emerging Mechanisms of Disease. Indian J Nephrol. 2024; 34(4):297-309.
PMC: 11326799.
DOI: 10.25259/ijn_425_23.
View